ingredient Deferasirox (400mg)/Diferasirox
substitutes Deferasirox (400mg)/Diferasirox
treatment Iron overload, Transfusion dependent thalassemia
Shipping class Room Temperature
Medicine Overview by Anukar Pharmacy
( Asunra 400mg 30 Tablet, Novartis )
TreatmentAsunra 400mg Tablet is used in the treatment of iron overload and transfusion dependent thalassemia.
Side EffectsNausea, Headache, Vomiting, Rash, Dyspepsia, Abdominal pain, Constipation, Itching, Increased liver enzymes, Abdominal distension, Diarrhoea.
Method of UseTake this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Asunra 400mg Tablet is to be taken empty stomach.
How Asunra 400mg 30 Tablet, Novartis WorksAsunra 400mg Tablet traps and removes excess iron which is then excreted mainly in the stools. This reduces the risk of organ damage.
More Info by Anukar Pharmacy
( Asunra 400mg 30 Tablet, Novartis )
Suggestions
- Always take deferasirox tablet on an empty stomach by dissolving into a glass of water.
- Do not chew, crush, break or swallow the tablets as a whole.
- Deferasirox may cause dizziness. It is advisable not to drive or operate any machinery until you feel normal again.
- Avoid taking deferasirox if you are pregnant, planning to become pregnant or are breast feeding.
Warning by Anukar Pharmacy
( Asunra 400mg 30 Tablet, Novartis )
Special precautions for Asunra 400mg 30 Tablet, Novartis Heads up
| aspect | highlight | details |
|---|---|---|
Alcohol
|
Interaction with alcohol is unknown. Please consult your doctor. | |
Pregnancy
|
WEIGH RISKS VS BENEFITS | Asunra 400mg Tablet may be unsafe to use during pregnancy. Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor. |
Lactation
|
Asunra 400mg Tablet is probably safe to use during lactation. Limited human data suggests that the drug does not represent a significant risk to the baby. | |
Driving
|
Asunra 400mg Tablet may make you feel dizzy, sleepy, tired, or decrease alertness. If this happens, do not drive. | |
Kidney
|
UNSAFE | Asunra 400mg Tablet is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor. |
Liver
|
caution | Asunra 400mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Asunra 400mg Tablet may be needed. Please consult your doctor. Limited information is available on the use of Asunra 400mg Tablet in these patients. |
Suggestion by Anukar Pharmacy on missing a dose
( Asunra 400mg 30 Tablet, Novartis )
If you miss a dose of Asunra 400mg Tablet, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
Disclaimer
The information of Anukar Pharmacy is for reference purpose only, and Anukar Pharmacy or Anukar Pharmacy or Anukar Pharmacy is not intended to be a replacement of professional medical advice, diagnosis, or treatment. Anukar Pharmacy suggest to ask the advice of a physician or any qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of anything you have learned from Anukar Pharmacy.
| 药名 | 地拉罗司, 恩瑞格 |
| 厂家 | 瑞士诺华 |
| 成分 | 本品主要成份为Deferasirox400mg |
| 说明 |
地拉罗司
商品名称 恩瑞格 通用名称 地拉罗司分散片 主要成份 成分为地拉罗司。 适应症 用于治疗年龄大于6岁的-地中海贫血患者因频繁输血（每月浓缩红细胞的给予量7mL/kg）所致慢性铁过载。Asunra （deferasirox）与铁结合并从血流中将其除去。Asunra用于治疗至少2岁的成人和儿童因输血而引起的铁超负荷。Asunra还用于治疗由遗传性血液疾病（非输血依赖性地中海贫血）引起的成年人和至少10岁的儿童引起的慢性铁超负荷综合征。
治疗作用：用于因需要长期输血而引致铁质积聚的患者(如患有地中海贫血症或其他罕见的贫血症) ，适用于两岁以上儿童及成人服用。贫血症、铁超负荷综合症
|
* 以上中文信息由印度阿努卡药房收集的Asunra 400mg 30 Tablet, Novartis（地拉罗司, 恩瑞格）中文网络信息和软件翻译获得，阿努卡药房认为Asunra 400mg 30 Tablet, Novartis（地拉罗司, 恩瑞格）中文产品介绍信息存在与Asunra 400mg 30 Tablet, Novartis（地拉罗司, 恩瑞格）实际数据不一致的可能。阿努卡药房请用户把Asunra 400mg 30 Tablet, Novartis（地拉罗司, 恩瑞格）页面数据作为参考。印度阿努卡药房建议用户在实际使用Asunra 400mg 30 Tablet, Novartis（地拉罗司, 恩瑞格）数据或者信息时，以Asunra 400mg 30 Tablet, Novartis（地拉罗司, 恩瑞格）制造商公开发布的Asunra 400mg 30 Tablet, Novartis（地拉罗司, 恩瑞格）商品信息为参考。使用方法，以用户医生建议使用Asunra 400mg 30 Tablet, Novartis（地拉罗司, 恩瑞格）决定为参考。用户任何关于Asunra 400mg 30 Tablet, Novartis（地拉罗司, 恩瑞格）的建议，可以通知印度阿努卡药房，或通知阿努卡在线客服人员。谢谢
